Midatech Pharma Plc EBIT

Midatech Pharma Plc (MTP) currently reports a EBIT of $-16M as of December 2025. That compares with $-6.6M in the prior-year period — down 140.1% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Midatech Pharma Plc's EBIT history and peer comparisons.

Midatech Pharma Plc's EBIT decreased from $-6.6M to $-16M — a 140.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Midatech Pharma Plc's EBIT of $-16M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Midatech Pharma Plc reported $-16M in EBIT as of December 2025. That compares with $-6.6M in the prior-year period — down 140.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-16M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Midatech Pharma Plc, and consider following MTP for alerts when major investors trade the stock.